Clinical trials
Phase 2 Blastic Plasmacytoid Dendritic Cell Neoplasm trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
| Recruiting | 3 |
| Completed | 2 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 5 |
| M.D. Anderson Cancer Center | 4 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| City of Hope Medical Center | 1 |
| French Innovative Leukemia Organisation | 1 |
| Mayo Clinic | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 13 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Leukemia, Biphenotypic, Acute | 6 |
| Leukemia, Myeloid, Acute | 6 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 |
| Myelodysplastic Syndromes | 4 |
| Burkitt Lymphoma | 2 |
| Hematologic Neoplasms | 2 |
| Hodgkin Disease | 2 |
| Leukemia, Mast-Cell | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.